pulmonary nodule
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.80 years old >= age>=18 years old, gender is not limited; 2. Preoperative diagnosis is mixed GGO or pure GGO with maximum lung diameter <=2cm and CTR <=0.25 found on chest CT; 3. Pumornary nodules located in the peripheral 1/3 of the lung, who are to undergo thoracoscopic lung wedge resection; 4. The patient gave informed consent and voluntarily sign the "Subject Informed Consent Form"
Exclusion criteria
Exclusion criteria: 1. Performing systematic mediastinal lymph node dissection during surgery; 2. Convert to thoracotomy during operation; 3. Those with severe pleural adhesion; 4. Those with severe coagulation abnormalities; 5. Patients with severe chronic obstructive pulmonary disease and emphysema; 6. Severe basic diseases of the heart, lungs, liver, kidneys and other organs; 7. Those whose life expectancy is less than 12 months; 8. Patients who are pregnant or lactating and in a life-critical situation; 9. Patients who have participated in any other clinical trials within 1 month; 10. Patients who have received lung anti-tumor treatment (radiotherapy, ablation, targeted, immunotherapy, chemotherapy) before surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extubation rate 4 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients without air leakage after surgery;Duration of postoperative air leakage (h);Air leakage at 12, 24, and 48 hours after surgery (ml);Postoperative pig tail tube extraction time (h);Postoperative hospital stay (days);Postoperative pain score (VAS score at rest and cough at 12h, 24h, 48h postoperatively);Postoperative re-insertion rate; | — |
Countries
China
Contacts
Shenzhen Third People's Hospital